Our Sites

The JHUBI-CTU integrates 3 highly productive Clinical Research Sites.

All three provide top-quality clinical care and clinical research at the same facility. Our sites are in urban areas most greatly affected by the HIV epidemic, and include the largest HIV clinic in Baltimore, India’s second largest HIV clinic, and YRGCARE CRS.  The JHUBI-CTU optimizes patient-oriented research and access to key populations affected by the HIV epidemic for participation in clinical trials.

The links above provide details about each site.

Clinical Trials

P1078: A Phase IV Randomized Double-Blind Placebo-Controlled...

P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More

A5384: A Phase II, Randomized, Open-Label Trial of a...

Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5322: Long-Term Follow-up of Older HIV-infected Adults in...

The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...

Read More